Leadership - Kinetiq
Our leaders share decades of experience in clinical research, compliance, regulatory analysis, and technology:
Executive Vice President
James Riddle, MCSE, CIP, CPIA, CRQM, is the executive vice president of Kinetiq, a research and technology consulting division of Quorum Review IRB. He offers nearly 20 years of experience leading private and academic programs in the healthcare, human subject protections, and lab animal care and use fields. James has served as the vice president of operations and director of technology at another major accredited central IRB, and as the assistant director in the Institutional Review Office of the Fred Hutch Cancer Research Center. His expertise includes reengineering operational processes, systems evaluations, development and implementation of technology solutions, integration of technology solutions with operations, and management of large Human Research Protection Programs (HRPP) and Institutional Animal Care and Use programs (IACUC). James has directed numerous clients in achieving Part 11 compliance and meeting computer system validation requirements. He is also adept at helping health systems and research institutes revitalize research administration.
James has served on the board of the Northwest Association for Biomedical Research (NWABR) and the steering committee of the Clinical Trials Transformation Initiative (CTTI). He has also served as a site visitor for the Association for the Accreditation of Human Research Protection Programs (AAHRPP). In addition to being on the editorial board of the journal IRB Advisor and the leadership team for the Alliance for Clinical Research Excellence and Safety (ACRES) Committee on Accreditation, he is a faculty member, mentor, and regular speaker for Public Responsibility in Medicine and Research (PRIM&R) and other industry conferences.
Chief Executive Officer
Cami Gearhart, JD, is the CEO of Quorum Review IRB. Under her leadership, Quorum has emerged as the premiere independent IRB and launched Kinetiq, the research and technology consulting division of Quorum Review that delivers innovative solutions to the challenges of human subject protection and compliance in clinical research. She holds undergraduate and Juris Doctor degrees from the University of Washington. Cami serves on the Clinical Trials Transformation Initiative (CTTI) Steering Committee and is Board President at the NWABR.
Chief Financial Officer
Jeff joined Quorum Review IRB, of which Kinetiq is the research and consulting division, as CFO in May, 2017. Previously, Jeff served as the CFO of a public technology and public services company. In addition, Jeff was the CFO for a privately held software company. Earlier in his career he worked in various finance positions with Siemens Medical Systems and with the international accounting firm of Pricewaterhouse Coopers. Jeff has a BS in Accounting from Oklahoma State University and is a Certified Public Accountant (CPA).
Chief Compliance and Security Officer
Toko joined Quorum Review IRB, of which Kinetiq is the research and technology consulting division, as a controller in 2003, and became the Vice President of Finance in 2005. In 2013, Toko was appointed Chief Financial Officer, and in early 2017, Toko became Chief Compliance and Security Officer, leading corporate governance and risk management functions. Prior to joining Kinetiq, Toko worked as a controller and divisional accounting manager for publicly held companies in food and forest product industries. Toko has a MBA from Seattle University and is a licensed Certified Management Accountant (CMA).
Executive Vice President and General Counsel, Quorum Review IRB
Before assuming his current role, Mitchell served as an associate attorney at the global law firm K&L Gates, consultant to the National Cancer Institute, and regulatory counsel to a global provider of medical research review services. Mitchell frequently speaks and writes on FDA, clinical trial, and IRB topics and is Faculty for the Regulatory Affairs Professionals Society (RAPS), a Steering Committee member for Harvard’s Multi-Regional Clinical Trial Center (MRCT), on the Board of Directors for Life Science Washington, and a member of PRIM&R. He is a member of the Washington and Oregon State Bars, is a CIP, and has his Regulatory Affairs Certification (RAC).